Mag Magna Corp. financial data

Industry
Medicinal Chemicals & Botanical Products
Location
325 W Washington St, Ste 2877, San Diego, California
State of incorporation
Wyoming
Fiscal year end
April 30
Latest financial report
Q4 2023 - Mar 8, 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5.66M shares
Common Stock, Shares, Outstanding 5.29M shares
Common Stock, Value, Issued 5.29K USD
Weighted Average Number of Shares Outstanding, Basic 4.5M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 5.29M shares +17.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 4.2K USD
General and Administrative Expense 6.28K USD -16.2%
Operating Income (Loss) 2.08K USD -72.2%
Net Income (Loss) Attributable to Parent -2.08K USD +72.3%
Earnings Per Share, Basic 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 11.5K USD
Assets, Current 11.5K USD
Intangible Assets, Net (Excluding Goodwill) 17.8K USD
Assets 37.8K USD
Liabilities, Current 46.7K USD
Liabilities 46.7K USD
Retained Earnings (Accumulated Deficit) 15.2K USD
Stockholders' Equity Attributable to Parent -8.83K USD +10.7%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -8.83K USD
Liabilities and Equity 37.8K USD

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -9.15K USD
Net Cash Provided by (Used in) Financing Activities 19.8K USD
Net Cash Provided by (Used in) Investing Activities -3.6K USD
Common Stock, Shares Authorized 75M shares
Common Stock, Shares, Issued 5.29M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 7.05K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 4.48K USD -0.49%
Interest Expense 6 USD +100%